| scholarly article | Q13442814 |
| P50 | author | David F Bauer | Q56027695 |
| Osama Elzafarany | Q95947148 | ||
| James M Markert | Q95947150 | ||
| Lawrence S Lamb | Q38324930 | ||
| P2093 | author name string | G Yancey Gillespie | |
| Larisa Pereboeva | |||
| Gretchen A Cloud | |||
| Catherine Langford | |||
| P2860 | cites work | Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation | Q59055770 |
| Direct vaccination with tumor cells killed with ICP4-deficient HSVd120 elicits effective antitumor immunity | Q79967743 | ||
| Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells | Q24290869 | ||
| The danger model: a renewed sense of self | Q28214633 | ||
| Tolerance, danger, and the extended family | Q29547532 | ||
| HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival | Q30954768 | ||
| Neuroblastoma grafts are noninvasively removed within mouse neocortex by selective laser activation of intracellular photolytic chromophore | Q33644037 | ||
| Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial | Q33905053 | ||
| A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L | Q34191248 | ||
| Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors | Q35051285 | ||
| Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model | Q35800497 | ||
| Vaccines Combined with Immune Checkpoint Antibodies Promote Cytotoxic T-cell Activity and Tumor Eradication | Q36540614 | ||
| Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer. | Q36643661 | ||
| Cancer vaccines: moving beyond current paradigms | Q36868126 | ||
| Molecular strategies for the treatment of malignant glioma--genes, viruses, and vaccines | Q37079854 | ||
| Dendritic-cell- and peptide-based vaccination strategies for glioma. | Q37392057 | ||
| Combining immunotherapy and targeted therapies in cancer treatment | Q37995939 | ||
| The impact of the TIM gene family on tumor immunity and immunosuppression | Q38171224 | ||
| Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme. | Q39695508 | ||
| Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas | Q40171214 | ||
| TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells | Q40246842 | ||
| MICA/NKG2D-mediated immunogene therapy of experimental gliomas. | Q40604072 | ||
| The flow cytometric PKH-26 assay for the determination of T-cell mediated cytotoxic activity | Q40637465 | ||
| Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma | Q40702544 | ||
| Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study | Q43166491 | ||
| Systemic T cell adoptive immunotherapy of malignant gliomas | Q47910243 | ||
| Genetically engineered herpes simplex viruses that express IL-12 or GM-CSF as vaccine candidates. | Q51332049 | ||
| Neuroblastoma | Q54265665 | ||
| Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas. | Q55475772 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 2568125 | |
| P577 | publication date | 2016-08-17 | |
| P1433 | published in | Journal of Immunology Research | Q26841936 |
| P1476 | title | Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma | |
| P478 | volume | 2016 |
| Q45323639 | Chimeric HCMV/HSV-1 and Δγ134.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory |
| Q99237685 | Developing preclinical models of neuroblastoma: driving therapeutic testing |
| Q90233130 | Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma |
| Q89682703 | Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy |
| Q55085319 | Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies. |
| Q90326778 | Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors |
Search more.